We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+10.44%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$796M
AUM Growth
-$270M
Cap. Flow
-$312M
Cap. Flow %
-39.23%
Top 10 Hldgs %
32.18%
Holding
376
New
126
Increased
36
Reduced
43
Closed
168

Top Buys

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$15M
2
PINC
Premier
PINC
+$12.9M
3
MDT icon
Medtronic
MDT
+$11.4M
4
GAP
The Gap Inc
GAP
+$9.98M
5
LSTR icon
Landstar System
LSTR
+$6.58M

Sector Composition

Rank Sector Weight
1 Industrials 7.99%
2 Consumer Discretionary 6.21%
3 Healthcare 5.01%
4 Technology 3.89%
5 Energy 3.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYX icon
126
NCR Voyix
VYX
$1.19B
$1.7M 0.21%
+81,500
New +$1.81M
KBR icon
127
CALL
KBR
KBR
$4.74B
$1.66M 0.21%
+52,100
New +$1.73M
CPN
128
CALL
DELISTED
Calpine Corporation
CPN
$1.56M 0.2%
+80,000
New +$1.56M
EWH icon
129
iShares MSCI Hong Kong ETF
EWH
$1.24B
$1.54M 0.19%
+75,000
New +$1.53M
BODY
130
DELISTED
BODY CENTRAL CORP COM STK
BODY
$1.53M 0.19%
389,290
-42,046
-10% -$182K
X
131
PUT
DELISTED
US Steel
X
$1.48M 0.19%
50,000
-75,000
-60% -$1.93M
AMAG
132
CALL
DELISTED
AMAG Pharmaceuticals
AMAG
$1.46M 0.18%
+60,000
New +$1.41M
FURX
133
CALL
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$1.45M 0.18%
+34,500
New +$1.42M
CAVM
134
DELISTED
Cavium, Inc.
CAVM
$1.41M 0.18%
+40,700
New +$1.52M
EXPR
135
DELISTED
Express, Inc.
EXPR
$1.38M 0.17%
+3,695
New +$1.63M
WTSL
136
DELISTED
WET SEAL INC CL-A
WTSL
$1.36M 0.17%
+500,000
New +$1.6M
HES
137
CALL
DELISTED
Hess
HES
$1.36M 0.17%
16,400
-14,200
-46% -$1.15M
CPN
138
DELISTED
Calpine Corporation
CPN
$1.36M 0.17%
69,639
+7,351
+12% +$143K
HZNP
139
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.33M 0.17%
175,000
-57,500
-25% -$310K
RPRX
140
PUT
DELISTED
Repros Therapeutics Inc.
RPRX
$1.33M 0.17%
72,500
+7,500
+12% +$142K
RYN icon
141
Rayonier
RYN
$6.64B
$1.26M 0.16%
+44,276
New +$1.43M
LPX icon
142
Louisiana-Pacific
LPX
$5.35B
$1.26M 0.16%
68,000
+19,000
+39% +$323K
MSCC
143
DELISTED
Microsemi Corp
MSCC
$1.25M 0.16%
+49,948
New +$1.21M
MSTR icon
144
Strategy Inc
MSTR
$35.1B
$1.24M 0.16%
100,000
-1,006,840
-91% -$11.9M
TAM
145
DELISTED
TAMINCO CORP COM
TAM
$1.21M 0.15%
+60,000
New +$1.22M
BEAM
146
CALL
DELISTED
BEAM INC COM STK (DE)
BEAM
$1.19M 0.15%
+17,500
New +$1.18M
OSUR icon
147
OraSure Technologies
OSUR
$277M
$1.18M 0.15%
187,500
+52,500
+39% +$330K
LTM
148
DELISTED
LIFE TIME FITNESS INC
LTM
$1.18M 0.15%
+25,082
New +$1.2M
ATRS
149
DELISTED
Antares Pharma, Inc.
ATRS
$1.17M 0.15%
+262,500
New +$1.07M
MDCO
150
DELISTED
Medicines Co
MDCO
$1.16M 0.15%
30,000
-233,750
-89% -$8.36M

Similar funds

J. Goldman & Co's Q4 2013 Portfolio in Review

As of Q4 2013, J. Goldman & Co held 376 positions worth $796M, down 25% from $1.07B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

J. Goldman & Co withdrew a net $312M in Q4 2013, closing 168 positions and reducing 43 holdings. Its most notable exit was Norwegian Cruise Line, an estimated $22M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 8% of assets, up from 6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, J. Goldman & Co opened a new position in Premier worth $14.3M.

  • J. Goldman & Co's largest Q4 2013 buy was Premier: 389,967 shares worth $14.3M.
  • J. Goldman & Co added most to Mercado Libre in Q4 2013, an estimated $15M increase.
  • J. Goldman & Co's biggest Q4 2013 reduction was Apple, cutting an estimated $49.1M.
  • J. Goldman & Co fully exited Norwegian Cruise Line in Q4 2013, selling an estimated $22M.
  • J. Goldman & Co's ten largest holdings make up 32% of its $796M portfolio in Q4 2013.
  • J. Goldman & Co opened 126 new positions and closed 168 in Q4 2013.
  • J. Goldman & Co's portfolio value fell 25% quarter-over-quarter to $796M.

Based on J. Goldman & Co's 13F filing for Q4 2013, filed 14 Feb 2014.